To investigate whether fisetin inhibited tumor growth through the AKT/HIF-1α signaling pathway, we found that fisetin could significantly reduce the levels of p-AKT, HIF-1α, and VEGF (P < 0.01) (Figure 5(b)). The gene discussed is VEGFA; the disease is neoplasm.